Blog
Articles on research peptides — storage, quality and practical know-how.
Retatrutide: What the Phase 3 Study Showed According to Dr. Brad Stanfield
Retatrutide is one of the most closely watched molecules in metabolic research in recent years. Dr. Brad Stanfield broke down the Phase 3 clinical trial results in detail on his channel — here's what the publicly available data showed, and how retatrutide compares to earlier generations of compounds.
Read article →What Is a Peptide Pen and How Does It Work?
Peptide pens are the most convenient format for working with research peptides today — no reconstitution, no insulin syringes, and a precise dosing mechanism. What exactly is a peptide pen and how does it differ from classic powder vials?
Read article →How to Store Peptide Pens Correctly
Peptide quality doesn't end at manufacture — how you handle the pen after receipt matters too. We summarize what most affects the stability of peptide pens and how to avoid needless degradation.
Read article →Retatrutide vs. Semaglutide vs. Tirzepatide: A Comparison
The three most-studied metabolic peptides — each targets a different number of receptors. What is the difference in their mechanism of action and how are they used in research?
Read article →